{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:41:11Z","timestamp":1787499671957,"version":"build-2736575974"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,30]]},"DOI":"10.18632\/oncotarget.10922","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T10:54:40Z","timestamp":1469789680000},"page":"56944-56957","source":"Crossref","is-referenced-by-count":25,"title":["IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E-cadherin in mice"],"prefix":"10.18632","volume":"7","author":[{"given":"Hye-Lin","family":"Ha","sequence":"first","affiliation":[{"name":"Disease Model Research Laboratory, Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea"},{"name":"Department of Functional Genomics, University of Science and Technology, Yuseong-gu, Daejeon, Republic of Korea"},{"name":"Present address: Immune Activation Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho","family":"Kwon","sequence":"additional","affiliation":[{"name":"Disease Model Research Laboratory, Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Seon","family":"Bak","sequence":"additional","affiliation":[{"name":"Disease Model Research Laboratory, Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Erikson","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Yeul","family":"Yu","sequence":"additional","affiliation":[{"name":"Disease Model Research Laboratory, Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea"},{"name":"Department of Functional Genomics, University of Science and Technology, Yuseong-gu, Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Jemal","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"3","first-page":"163","article-title":"Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis","volume":"26","author":"Di Coscio","year":"1994","journal-title":"Ital J Gastroenterol"},{"key":"4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"DePinho","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.22765","article-title":"Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B","volume":"49","author":"Okazaki","year":"2009","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8278(99)80172-X","article-title":"Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein","volume":"31","author":"Lee","year":"1999","journal-title":"J Hepatol"},{"key":"7","first-page":"777","article-title":"Expression of pituitary tumor-transforming gene 1 (PTTG1)\/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation","volume":"51","author":"Lopez-Cabrera","journal-title":"Hepatology"},{"key":"8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/MCB.18.3.1562","article-title":"Hepatitis B virus pX targets TFIIB in transcription coactivation","volume":"18","author":"Shaul","year":"1998","journal-title":"Mol Cell Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.1840130217","article-title":"Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma","volume":"13","author":"Williams","year":"1991","journal-title":"Hepatology"},{"key":"10","first-page":"3831","article-title":"Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product","volume":"56","author":"Lee","year":"1996","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.510280113","article-title":"Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver","volume":"28","author":"Imaoka","year":"1998","journal-title":"Hepatology"},{"key":"12","first-page":"38","article-title":"The IGF system in childhood: physiology and clinical implications","volume":"28","author":"Argente","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.1712","article-title":"Insulin-like growth factor ligands, receptors, and binding proteins in cancer","volume":"205","author":"Hassan","year":"2005","journal-title":"J Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","article-title":"Role of insulin-like growth factors in embryonic and postnatal growth","volume":"75","author":"Efstratiadis","year":"1993","journal-title":"Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nm0396-311","article-title":"Somatic overgrowth associated with overexpression of insulin-like growth factor II","volume":"2","author":"Reeve","year":"1996","journal-title":"Nat Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Beug","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000147753","article-title":"Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo","volume":"154","author":"Viebahn","year":"1995","journal-title":"Acta Anat (Basel)"},{"key":"18","first-page":"820","article-title":"Epithelial-mesenchymal transition in cultured neonatal hepatocytes","volume":"21","author":"Vilaro","year":"1995","journal-title":"Hepatology"},{"key":"19","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1158\/0008-5472.CAN-05-0616","article-title":"Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?","volume":"65","author":"Tarin","year":"2005","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrm1175","article-title":"Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis","volume":"4","author":"Beug","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.10083","article-title":"Cadherin and catenin alterations in human cancer","volume":"34","author":"Fearon","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"23","first-page":"1613","article-title":"The SLUG zinc-finger protein represses E-cadherin in breast cancer","volume":"62","author":"Fearon","year":"2002","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Garcia De Herreros","year":"2000","journal-title":"Nat Cell Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1038\/sj.onc.1204660","article-title":"IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition","volume":"20","author":"Larue","year":"2001","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.cellbio.16.1.591","article-title":"SUMO--nonclassical ubiquitin","volume":"16","author":"Melchior","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ncb1415","article-title":"Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis","volume":"8","author":"Baek","year":"2006","journal-title":"Nat Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2005.03.012","article-title":"SUMO: a history of modification","volume":"18","author":"Hay","year":"2005","journal-title":"Mol Cell"},{"key":"29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","article-title":"SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia","volume":"131","author":"Yeh","year":"2007","journal-title":"Cell"},{"key":"30","doi-asserted-by":"crossref","first-page":"34167","DOI":"10.1074\/jbc.M706505200","article-title":"Ubiquitin-dependent proteolytic control of SUMO conjugates","volume":"282","author":"Dohmen","year":"2007","journal-title":"J Biol Chem"},{"key":"31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13651820410024049","article-title":"Diagnosis of hepatocellular carcinoma","volume":"7","author":"Di Bisceglie","year":"2005","journal-title":"HPB (Oxford)"},{"key":"32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10024001-0003-8","article-title":"Nesidioblastosis and mixed hamartoma of the liver in Beckwith-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting","volume":"4","author":"Hata","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hep.22297","article-title":"Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis","volume":"48","author":"Breuhahn","year":"2008","journal-title":"Hepatology"},{"key":"34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3892\/ijo.2012.1666","article-title":"The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review)","volume":"41","author":"Adamek","year":"2012","journal-title":"Int J Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Derynck","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"36","first-page":"1517","article-title":"Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro","volume":"23","author":"Coppola","year":"2003","journal-title":"Anticancer Res"},{"key":"37","first-page":"655","article-title":"Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation","volume":"11","author":"Wang","year":"2000","journal-title":"Cell Growth Differ"},{"key":"38","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1210\/en.2003-0350","article-title":"Parallel phosphatidylinositol-3 kinase and p42\/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells","volume":"144","author":"Cornish","year":"2003","journal-title":"Endocrinology"},{"key":"39","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1016\/j.febslet.2006.09.003","article-title":"JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes","volume":"580","author":"Santibanez","year":"2006","journal-title":"FEBS Lett"},{"key":"40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2006.03.048","article-title":"p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation","volume":"125","author":"Niswander","year":"2006","journal-title":"Cell"},{"key":"41","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1074\/jbc.M000089200","article-title":"Mechanism of STAT3 activation by insulin-like growth factor I receptor","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-9966-28-28","article-title":"Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells","volume":"28","author":"Hong","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/0008-5472.CAN-06-1479","article-title":"Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1242\/jcs.114.1.111","article-title":"Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1","volume":"114","author":"Mareel","year":"2001","journal-title":"J Cell Sci"},{"key":"45","first-page":"3289","article-title":"Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor\/scatter factor-induced cell-cell dissociation and in vitro invasion","volume":"7","author":"Mason","year":"2001","journal-title":"Clin Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000101452","article-title":"Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells","volume":"39","author":"Kim","year":"2007","journal-title":"Eur Surg Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1073\/pnas.0500918102","article-title":"ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation","volume":"102","author":"Saftig","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/MCB.00172-06","article-title":"MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation","volume":"26","author":"Hung","year":"2006","journal-title":"Mol Cell Biol"},{"key":"49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ncb758","article-title":"Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex","volume":"4","author":"Birchmeier","year":"2002","journal-title":"Nat Cell Biol"},{"key":"50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/HMER.S16316","article-title":"Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics","volume":"4","author":"Cabrera","year":"2012","journal-title":"Hepat Med"},{"key":"51","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","article-title":"Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma","volume":"132","author":"Cheong","year":"2007","journal-title":"Gastroenterology"},{"key":"52","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/sj.onc.1201760","article-title":"The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4","volume":"16","author":"Poo","year":"1998","journal-title":"Oncogene"},{"key":"53","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1074\/jbc.275.9.6252","article-title":"Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2\/3","volume":"275","author":"Hinchey","year":"2000","journal-title":"J Biol Chem"},{"key":"54","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1074\/jbc.M209694200","article-title":"The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and \u22122 conjugates is increased by stress","volume":"278","author":"Vierstra","year":"2003","journal-title":"J Biol Chem"},{"key":"55","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2005.04.012","article-title":"Gender-dependent hepatic alterations in H-ras12V transgenic mice","volume":"43","author":"Yu","year":"2005","journal-title":"J Hepatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T04:29:35Z","timestamp":1656908975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":55,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,8,30]]}},"alternative-id":["10922","27486970"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10922","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}